Pattern of Treatment and Outcomes of Locally Advanced Rectal Carcinoma
ConditionRectal Carcinoma
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorSohag University
About this trial
the study will discuss different pattern of treatment and the outcomes of locally advanced rectal carcinoma as a retrospective study.
The study will be conducted at Department of Clinical Oncology, Sohag University Hospital and Sohag Cancer center, Sohag, Egypt.
including patients diagnosed and treated between 2018 and 2025. and the data will be collected from reports .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients who were more than18 years old at time of diagnosis.
Patients with histologically confirmed rectal carcinoma.
Stage II-III (locally advanced) disease at initial diagnosis.
Disqualifiers
Patients with distant metastasis at presentation.
Patients diagnosed with double malignancy.
Patients with incomplete medical records.
Organ failure
Trial population
The study will be conducted at Department of Clinical Oncology, Sohag University Hospital and Sohag Cancer center, Sohag, Egypt.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
No Intervention (subjects were previously treated with Onglyza®)
Other interventionno intervention
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Estimation of overall survival (OS ).
Time frame
2018 _ 20252
Estimation of Response rate .
Time frame
2018-20253
Estimation of disease-free survival (DFS) .
Time frame
2018-2025Secondary outcomes
1
treatment-related toxicity: (graded by CTCAE v5).
Time frame
2018-2025Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: